18F-FDG maximum standard uptake value predicts PD-L1 expression on tumor cells or tumor-infiltrating immune cells in non-small cell lung cancer

B Hu, W Chen, Y Zhang, H Shi, D Cheng… - Annals of Nuclear Medicine, 2020 - Springer
Objectives Programmed cell death-ligand 1 (PD-L1) is expressed on tumor cells (TC) and
tumor-infiltrating immune cells (IC). We conducted a retrospective study to investigate the …

Combining PD-L1 expression and standardized uptake values in FDG-PET/CT can predict prognosis in patients with resectable non–small-cell lung cancer

T Miyazawa, K Otsubo, H Sakai, H Kimura… - Cancer …, 2021 - journals.sagepub.com
Background This study aimed to determine the relationship of programmed death-ligand 1
(PD-L1) expression and standardized uptake values in fluorodeoxyglucose–positron …

Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically …

B Hu, J Xiao, Y Xiu, Z Fu, H Shi… - Nuclear Medicine …, 2020 - journals.lww.com
Objective The uptake of 18 F-fluorodeoxyglucose (18 F-FDG) PET/computed tomography
(CT) is known to be linked to programmed death ligand 1 (PD-L1) expression on tumor cells …

[HTML][HTML] Prognostic significance of PD-L1 expression and 18F-FDG PET/CT in surgical pulmonary squamous cell carcinoma

M Zhang, D Wang, Q Sun, H Pu, Y Wang, S Zhao… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Programmed cell death-ligand 1 (PD-L1) expression is commonly observed in non-small
cell lung cancer (NSCLC). The prognostic value of PD-L1 expression and the maximum …

Metabolic characteristics of programmed cell death‐ligand 1‐expressing lung cancer on 18F‐fluorodeoxyglucose positron emission tomography/computed …

K Takada, G Toyokawa, T Okamoto, S Baba… - Cancer …, 2017 - Wiley Online Library
Abstract Programmed cell death‐1 (PD‐1) and programmed cell death‐ligand 1 (PD‐L1)
have been identified as novel targets of immunotherapy of lung cancer. In present study, we …

18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer

M Jreige, I Letovanec, K Chaba, S Renaud… - European journal of …, 2019 - Springer
Abstract Purpose Anti-PD-1/PD-L1 blockade can restore tumour-specific T-cell immunity and
is an emerging therapy in non-small-cell lung cancer (NSCLC). We investigated the …

The value of 18F-FDG PET/CT in predicting the response to PD-1 blocking immunotherapy in advanced NSCLC patients with high-level PD-L1 expression

K Vekens, H Everaert, B Neyns, B Ilsen, L Decoster - Clinical lung cancer, 2021 - Elsevier
Background The objective of this study was to evaluate if 18 F-fluorodeoxyglucose positron
emission tomography/computed tomography (18 F-FDG PET/CT)-derived parameters are …

Relationship between SP142 PD‐L1 Expression and 18F‐FDG Uptake in Non‐Small‐Cell Lung Cancer

L Zhao, J Liu, J Shi, H Wang - Contrast Media & Molecular …, 2020 - Wiley Online Library
Objectives. Immune checkpoint blockers constitute the first‐line treatment for advanced non‐
small‐cell lung cancer (NSCLC) with≥ 50% PD‐L1 expression. In NSCLC, PD‐L1 positivity …

[HTML][HTML] The predictive value of total-body PET/CT in non-small cell lung cancer for the PD-L1 high expression

B Hu, H Jin, X Li, X Wu, J Xu, Y Gao - Frontiers in Oncology, 2022 - frontiersin.org
Purpose: Total-body positron-emission tomography/computed tomography (PET/CT)
provides faster scanning speed, higher image quality and lower injected dose. To …

The association between imaging features of TSCT and the expression of PD-L1 in patients with surgical resection of lung adenocarcinoma

T Wu, F Zhou, AK Soodeen-Lalloo, X Yang, Y Shen… - Clinical Lung Cancer, 2019 - Elsevier
Objectives Programmed death-ligand 1 (PD-L1) expression might serve as a predictive
biomarker for immune checkpoint inhibitors in lung cancer. However, the relationship …